Protease Inhibitor
48 drugs across 18 manufacturers|35 Generic,13 Brand
The Protease Inhibitor class contains 48 NDCs from 18 manufacturers (35 generic, 13 brand), at an average NADAC of $11.44 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
48
35G / 13B
Manufacturers
18
Avg $11.4379/unit
Avg 7d Change
+1.10%
Across 36 drugs with changes
7d Activity
of 48 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Frequently Asked Questions
How many drugs are in the Protease Inhibitor class?
The Protease Inhibitor class contains 48 NDCs from 18 manufacturers — 35 generic and 13 brand products.
What is the average price of Protease Inhibitor drugs?
The average NADAC for the Protease Inhibitor class is $11.4379 per unit across 48 NDCs.
Is generic cheaper than brand in the Protease Inhibitor class?
The average generic NADAC in this class is $1.7806 per unit, versus $39.6398 for brand — generic is about 96% cheaper on average.
Which manufacturers make Protease Inhibitor drugs?
18 manufacturers make drugs in the Protease Inhibitor class. Ranked by number of NDCs, the largest are Camber Pharmaceuticals Inc. (6), Aurobindo Pharma Limited (5), Janssen Products LP (4), AbbVie Inc. (4), E.R. Squibb & Sons, L.L.C. (3).
How has Protease Inhibitor pricing changed recently?
Over the past 7 days, 31 NDCs in this class rose and 5 fell, with a class-wide average change of +1.1%.
Manufacturer Breakdown
18 manufacturers producing drugs in this therapeutic class(3 pricing outliers)
and 6 more manufacturers